Early E/M insights, Part II: Solve confusion surrounding MDM rules

Why This Topic Matters

The article helps readers understand where the revised outpatient E/M rules create uncertainty, especially around data review, separately reported testing services, and audit risk. That makes it relevant for practices trying to document and defend E/M level selection consistently under the 2021 guidelines.

Article Sections

1. Overview of the 2021 outpatient E/M guidelines

   Introduces the revised outpatient E/M framework and the role of medical decision-making in level selection. Summarizes the major elements used in the updated approach.

2. Interpreting the guidelines for data review

   Discusses how diagnostic testing and review activities are treated under the revised guidance. Addresses areas where technical corrections and payer interpretation have affected documentation and counting of data review activities.

3. Billing considerations

   Covers payment and billing issues that may affect whether certain services can be considered in the encounter analysis. Notes concerns involving facility billing, outside testing locations, and practice-level reimbursement structures.

4. Audit issues

   Reviews potential audit focus areas related to time-based reporting, prolonged services, and medical decision-making documentation. Highlights the types of documentation and claim patterns that may draw scrutiny under the new guidelines.